NO954389L - Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte - Google Patents

Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Info

Publication number: NO954389L
Authority: NO; Norway
Prior art keywords: salt; squalene synthetase; synthetase inhibitor; phosphonosulfonate; inhibitor salts
Prior art date: 1994-11-03

Application number

NO954389A

Other languages

English (en)

Norwegian (no)

Other versions

NO954389D0 (no

Inventor

Yadagiri Pendri

Chung Pin Chen

David J Kucera

Eduardo J Martinez

Paul D Pansegrau

John K Thottathil

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-03

Filing date

1995-11-02

Publication date

1996-05-06

1995-11-02 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1995-11-02 Publication of NO954389D0 publication Critical patent/NO954389D0/no

1996-05-06 Publication of NO954389L publication Critical patent/NO954389L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)

NO954389A 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte NO954389L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33366194A	1994-11-03	1994-11-03

Publications (2)

Publication Number	Publication Date
NO954389D0 NO954389D0 (no)	1995-11-02
NO954389L true NO954389L (no)	1996-05-06

Family

ID=23303735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO954389A NO954389L (no)	1994-11-03	1995-11-02	Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Country Status (14)

Country	Link
EP (1)	EP0710665A1 (2)
JP (1)	JPH08208672A (2)
KR (1)	KR960017680A (2)
CN (1)	CN1130188A (2)
AU (1)	AU3458795A (2)
CA (1)	CA2159850A1 (2)
CZ (1)	CZ279595A3 (2)
FI (1)	FI955256L (2)
HU (1)	HUT73140A (2)
IL (1)	IL115537A0 (2)
NO (1)	NO954389L (2)
PL (1)	PL311218A1 (2)
TW (1)	TW318852B (2)
ZA (1)	ZA959326B (2)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2780974B1 (fr) *	1998-07-08	2001-09-28	Sod Conseils Rech Applic	Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
US20040063750A1 (en) *	2000-11-09	2004-04-01	Tomoyuki Nishimoto	High-density lipoprotein-cholesterol level elevating agent
EP1881760A4 (en)	2005-04-18	2009-03-25	Univ California	ANTIMICROBIAL THERAPY OF BACTERIAL INFECTIONS
EP2020857A4 (en)	2006-05-12	2010-06-09	Univ California	ANTIMICROBIAL THERAPY OF BACTERIAL INFECTIONS
CN101580472B (zh) *	2009-06-24	2013-07-10	广西壮族自治区化工研究院	1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2107644A1 (en) *	1992-10-28	1994-04-29	David R. Magnin	.alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
US5312814A (en) *	1992-12-09	1994-05-17	Bristol-Myers Squibb Co.	α-phosphonocarboxylate squalene synthetase inhibitors

1995
- 1995-10-04 CA CA002159850A patent/CA2159850A1/en not_active Abandoned
- 1995-10-06 IL IL11553795A patent/IL115537A0/xx unknown
- 1995-10-25 CZ CZ952795A patent/CZ279595A3/cs unknown
- 1995-10-26 EP EP95307618A patent/EP0710665A1/en not_active Withdrawn
- 1995-10-27 JP JP7280397A patent/JPH08208672A/ja active Pending
- 1995-11-02 NO NO954389A patent/NO954389L/no unknown
- 1995-11-02 TW TW084111593A patent/TW318852B/zh active
- 1995-11-02 HU HU9503136A patent/HUT73140A/hu unknown
- 1995-11-02 PL PL95311218A patent/PL311218A1/xx unknown
- 1995-11-02 FI FI955256A patent/FI955256L/fi not_active Application Discontinuation
- 1995-11-02 AU AU34587/95A patent/AU3458795A/en not_active Abandoned
- 1995-11-03 KR KR1019950039576A patent/KR960017680A/ko not_active Withdrawn
- 1995-11-03 CN CN95119023A patent/CN1130188A/zh active Pending
- 1995-11-03 ZA ZA959326A patent/ZA959326B/xx unknown

Also Published As

Publication number	Publication date
CN1130188A (zh)	1996-09-04
NO954389D0 (no)	1995-11-02
CA2159850A1 (en)	1996-05-04
HUT73140A (en)	1996-06-28
TW318852B (2)	1997-11-01
FI955256A0 (fi)	1995-11-02
IL115537A0 (en)	1996-01-19
FI955256A7 (fi)	1996-05-04
HU9503136D0 (en)	1995-12-28
CZ279595A3 (en)	1996-08-14
AU3458795A (en)	1996-05-09
EP0710665A1 (en)	1996-05-08
JPH08208672A (ja)	1996-08-13
FI955256L (fi)	1996-05-04
KR960017680A (ko)	1996-06-17
ZA959326B (en)	1997-05-05
PL311218A1 (en)	1996-05-13

Similar Documents

Publication	Publication Date	Title
IL111670A0 (en)	1995-01-24	Isoxazoline compounds as antiinflammatory agents
MX9804623A (es)	1998-10-31	Precursores inactivos de farmacos inhibidores de trombina.
DK327689D0 (da)	1989-06-30	Diphosphonsyrederivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
FI924427A0 (fi)	1992-10-01	Bensylfosfonsyratyrosinkinas -inhibitorer.
SG52659A1 (en)	1998-09-28	Saccharin derivative proteolytic enzyme inhibitors
BR0010220A (pt)	2002-05-14	Compostos de pirimidinona
CA2144372A1 (en)	1995-09-15	Composition for water treatment
EP1143957A3 (en)	2002-02-27	Treatment of arthritis with mek inhibitors
GR3032506T3 (en)	2000-05-31	3-aryl-2-isoxazolines as antiinflammatory agents
NZ294933A (en)	1999-05-28	Thienopyridine or thienopyrimidine derivatives, pharmaceutical compositions and use as anti-inflammatory agents
AU7107496A (en)	1997-04-17	Protein tyrosine kinase inhibitors for treating osteoarthritis
AP9701007A0 (en)	1997-07-31	Substituted azetidin-2-ones for treatment of atherosclerosis.
MY116539A (en)	2004-02-28	New amino acid derivatives
CA2020858A1 (en)	1991-01-15	Water treatment agent and water treatment method for boiler
BR9916272A (pt)	2001-09-04	4 e 5-alquiniloxindóis e 4 e 5-alqueniloxindóis
FI953157A0 (fi)	1995-06-26	Ympärist¦lietteen käsittelymenetelmä
NO954389L (no)	1996-05-06	Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte
BR0002297A (pt)	2001-05-22	Aditivo de gênero alimentìcio que contém ácido d-pantotênico e/ou seus sais e um processo para a sua preparação
MA23790A1 (fr)	1996-10-01	Procede pour desactiver ou detruire des microorganismes
AU2157500A (en)	2000-07-31	Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
TR200402670T4 (tr)	2004-11-22	Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem
NO982081L (no)	1998-06-05	Syntetiske mineralmikropartikler og retensjonshjelpemidler og vannbehandlingssystemer og fremgangsmÕter ved anvendelse av slike partikler
DK0712278T3 (da)	2001-09-03	N-pyridyltoluidinholdigt svampedræbende, vanddispergerbart granulat
MY112593A (en)	2001-07-31	A storage stable water solution for infusion containing a thrombin inhibitor
BG104292A (en)	2000-12-29	Methods and compositions for the treatment of rheumatoid arthritis